Skip to main content
. 2026 May 19;16:354. doi: 10.1038/s41398-026-04096-1

Table 2.

Distribution of hippocampal volume, fractional anisotropy (FA) and cerebral blood flow (CBF) at Year 30 and cumulative exposure to cannabis in ‘cannabis-years’ among 648 CARDIA participants at the Year 30 MRI sub-study, excluding participants with a history of stroke or TIA.

NEVER TOBACCO SMOKING All (340) Never user Ever Cannabis Usea
1 day to 0.5 cannabis years 0.5 to < 2 cannabis years > 2 cannabis years
Volume Hippocampus (mm3), mean (SD) 3836 (413) 3800 (425) 3803 (421) 3919 (338) 3950 (445)
FA Fornix, mean (SD) 0.266 (0.035) 0.273 (0.034) 0.263 (0.036) 0.271 (0.036) 0.259 (0.031)
CBF Hippocampus (ml/100 g/min), mean (SD) 41.781 (9.941) 42.898 (10.397) 42.292 (8.773) 38.903 (10.091) 41.291 (13.332)
EVER TOBACCO SMOKING All (308) Never user Ever Cannabis Usea
1 day to 0.5 cannabis years 0.5 to < 2 cannabis years > 2 cannabis years
Volume Hippocampus (mm3), mean (SD) 3749 (397) 3652 (496) 3714 (390) 3789 (395) 3766 (384)
FA Fornix, mean (SD) 0.262 (0.036) 0.258 (0.023) 0.260 (0.036) 0.270 (0.036) 0.257 (0.038)
CBF Hippocampus (ml/100 g/min), mean (SD) 42.172 (8.770) 44.944 (6.835) 42.187 (9.112) 40.629 (7.705) 43.042 (9.879)

Stratified by ever tobacco smoking.

FA fractional anisotropy, CBF cerebral blood flow, CARDIA coronary artery risk development in young adults study, N number of participants; +-SD standard deviation.

aSelf-reported cumulative exposure to cannabis in cannabis-years; 1 cannabis-year of exposure = 365 days of cannabis use (1 year × 365 days/y).